Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2026-03-02 @ 8:37 PM
Study NCT ID:
NCT00967967
Status:
SUSPENDED
Last Update Posted:
2013-05-27
First Post:
2009-08-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Validation of the Rhinitis Control Scoring System (RCSS)
Sponsor:
Laval University
Organization:
Study Overview
Official Title:
Validation of a Rhinitis Control Tool : the Rhinitis Control Scoring System (RCSS)
Status:
SUSPENDED
Status Verified Date:
2013-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Awaiting results from sub analysis to decide if study continuesé
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RCSS
Brief Summary:
Many patients suffering from allergic rhinitis do not recognize or perceive their symptoms. Instruments have been developed to assess quality of life in rhinitis, asthma or both, but there is a need to develop validated tools or methods to assess rhinitis control among rhinitis and/or asthmatic patients. The aim of this study is to assess the discriminative and evaluative properties of the RCSS in asthmatic patients with allergic rhinitis.
Detailed Description:
Allergic asthmatic subjects showing seasonal rhinitis symptoms will be recruited. The discriminative (internal consistency, cross sectional construct validity and reliability) and evaluative (responsiveness and longitudinal construct validity) properties of the RCSS will be evaluated as well as the relationship between rhinitis control and asthma control. RCSS will be completed at various time points during the seasonal allergic period.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: